HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway

Maria E Ramos-Nino1, Steven R Blumen, Tara Sabo-Attwood

  • 1University of Vermont College of Medicine, Department of Pathology, 89 Beaumont Avenue HSRF#216, Burlington, VT 05405, USA. Maria.Ramos@uvm.edu

Insights

Hepatocyte growth factor (HGF) drives malignant mesothelioma (MM) growth via a novel pathway involving ERK5 and Fra-1. Inhibiting this pathway may offer new MM treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Hepatocyte growth factor (HGF) and its receptor c-Met are highly expressed in malignant mesotheliomas (MMs).
  • HGF/c-Met signaling may promote MM growth and survival.
  • Fos-related antigen 1 (Fra-1) was previously shown to inhibit c-Met expression in rat mesotheliomas.

Purpose of the Study:

  • To investigate the role of Fra-1 in HGF-induced proliferation in human MMs.
  • To elucidate the signaling pathway mediating HGF effects in MMs.

Main Methods:

  • Human MM cell lines were treated with HGF.
  • RNA silencing (knockdown) and overexpression of Fra-1 were performed.
  • Expression of Fra-1, ERK5, AKT, and MEK5 was analyzed at mRNA and protein levels.
  • Cell viability and proliferating cell nuclear antigen (PCNA) expression were assessed.
  • Stable MM cell lines with dominant-negative MEK5 (dnMEK5) were generated.

Main Results:

  • HGF increased Fra-1 levels and phosphorylation of ERK5 and AKT in some MM lines.
  • These effects were inhibited by a PI3K inhibitor (LY290042).
  • Fra-1 knockdown decreased HGF-dependent phosphorylation and Fra-1 expression.
  • Fra-1 overexpression blocked MEK5 expression.
  • dnMEK5 expression led to increased basal Fra-1 levels.
  • HGF-induced MM cell viability and PCNA expression were abolished by MEK5 or Fra-1 knockdown.

Conclusions:

  • HGF-induced MM cell proliferation and viability are mediated by a novel PI3K/ERK5/Fra-1 feedback pathway.
  • This pathway may explain the tumor-specific effects of c-Met inhibitors in MMs and other cancers.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...